Jasper Therapeutics Stock Forecast

JSPR's stock price has decreased by -82.29% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 9 professional analysts, the 12-month price target for Jasper Therapeutics stock ranges from a low of $4.00 to a high of $65. The average analyst price target of $31.67 forecasts a 966.33% increase in the stock price over the next year.

Price Target: $31.67 (+966.33%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$31.67	$20	$65
Change	+34.68%	+966.33%	+573.40%	+2088.6%

* Price targets were last updated on Jul 8, 2025.

Analyst Ratings

The average analyst rating for Jasper Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	4	4	4	4	3	3
Buy	7	7	7	7	6	6
Hold	0	0	0	0	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kostas Biliouris BMO Capital	BMO Capital	Buy → Hold Downgrades $15 → $4	Buy → Hold	Downgrades	$15 → $4	+34.68%	Jul 8, 2025
Silvan Tuerkcan JMP Securities	JMP Securities	Buy Maintains $70 → $12	Buy	Maintains	$70 → $12	+304.04%	Jul 8, 2025
Gavin Clark-Gartner Evercore ISI Group	Evercore ISI Group	Buy Maintains $50 → $20	Buy	Maintains	$50 → $20	+573.40%	Jul 8, 2025
Matt Phipps William Blair	William Blair	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Jul 7, 2025
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $40 → $20	Strong Buy	Maintains	$40 → $20	+573.40%	Jul 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-4.81

from -4.89

EPS Next Year

-4.31

from -4.81

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-	221.60K
Revenue Growth	-	-	-	-	-	-	-	-
EPS	-183.08	-26.89	-10.33	-6.18	-4.89	-4.81	-4.31	-4.63
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	13	13	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	912,450
Avg	n/a	n/a	221,595
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-3.61	-0.97	-0.93
Avg	-4.81	-4.31	-4.63
Low	-5.99	-7.22	-8.58

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.